Can you provide the last earnings date for TRANSMEDICS GROUP INC?
TRANSMEDICS GROUP INC (TMDX) last reported earnings on 2/24/2026.
TRANSMEDICS GROUP INC (TMDX) Earnings History & Surprises
NASDAQ:TMDX • US89377M1099
Current stock price
124.7 USD
+1.22 (+0.99%)
At close:
125.5 USD
+0.8 (+0.64%)
After Hours:
TMDX Earnings overview
Past quarterly earnings results for TRANSMEDICS GROUP INC (TMDX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.64
- Revenue Estimate
- 177.36M
Last Reported
Most Recent- Release Date
- Feb 24, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.53
- EPS Surprise
- 32.92%
- Revenue Surprise
- 1.22%
Beat Rate
Last 8 Quarters 81%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.53 | 0.40 | 32.92% | 178.95% | 160.764M | 158.83M | 1.22% | 32.18% |
| Q3 2025 | 0.66 | 0.36 | 84.39% | 450.00% | 143.823M | 148.16M | -2.93% | 32.24% |
| Q2 2025 | 0.92 | 0.46 | 100.04% | 162.86% | 157.37M | 150.82M | 4.34% | 37.68% |
| Q1 2025 | 0.70 | 0.26 | 167.38% | 100.00% | 143.537M | 126.13M | 13.80% | 48.21% |
| Q4 2024 | 0.19 | 0.16 | 16.42% | 58.33% | 121.624M | 112.49M | 8.12% | 49.83% |
| Q3 2024 | 0.12 | 0.30 | -59.86% | 115.38% | 108.761M | 117.3M | -7.28% | 63.72% |
| Q2 2024 | 0.35 | 0.21 | 63.40% | 1,266.67% | 114.305M | 100.95M | 13.23% | 117.87% |
| Q1 2024 | 0.35 | -0.04 | 957.84% | 537.50% | 96.85M | 85.453M | 13.34% | 133.07% |
| Q4 2023 | 0.12 | -0.06 | 289.75% | 157.14% | 81.174M | 69.877M | 16.17% | 158.68% |
| Q3 2023 | -0.78 | -0.16 | -373.00% | -212.00% | 66.43M | 50.172M | 32.40% | 158.68% |
| Q2 2023 | -0.03 | -0.13 | 77.38% | 92.68% | 52.465M | 43.268M | 21.26% | 155.68% |
| Q1 2023 | -0.08 | -0.25 | 68.12% | 78.95% | 41.554M | 38.684M | 7.42% | 161.68% |
| Q4 2022 | -0.21 | -0.31 | 31.37% | 54.35% | 31.38M | 24.942M | 25.81% | 224.51% |
| Q3 2022 | -0.25 | -0.42 | 40.51% | 46.81% | 25.68M | 19.253M | 33.38% | 378.21% |
| Q2 2022 | -0.41 | -0.35 | -15.51% | -5.13% | 20.52M | 16.601M | 23.61% | 151.16% |
| Q1 2022 | -0.38 | -0.39 | 1.96% | -31.03% | 15.88M | 9.84M | 61.38% | 125.25% |
| Q4 2021 | -0.46 | -0.43 | -6.36% | -100.00% | 9.67M | 7.676M | 25.98% | 26.74% |
| Q3 2021 | -0.47 | -0.36 | -29.43% | -147.37% | 5.37M | 6.477M | -17.09% | -24.26% |
| Q2 2021 | -0.39 | -0.29 | -35.59% | -8.33% | 8.17M | 7.701M | 6.09% | 141.00% |
| Q1 2021 | -0.29 | -0.30 | 2.63% | 30.95% | 7.05M | 7.242M | -2.65% | -6.37% |
| Q4 2020 | -0.23 | -0.25 | 9.08% | - | 7.63M | 6.171M | 23.64% | - |
| Q3 2020 | -0.19 | -0.33 | 41.79% | - | 7.09M | 5.661M | 25.24% | - |
| Q2 2020 | -0.36 | -0.43 | 16.36% | - | 3.39M | 2.805M | 20.86% | - |
| Q1 2020 | -0.42 | -0.40 | -3.98% | - | 7.53M | 7.292M | 3.26% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
96.18%
Max EPS beat (4)
167.38%
Min EPS beat (4)
32.92%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
4.11%
Max Revenue beat (4)
13.80%
Min Revenue beat (4)
-2.93%
Analysis
In the last 4 quarters, TMDX has consistently beaten EPS estimates in all releases
TMDX has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, TMDX has beaten the EPS estimates by 96.2% on average.
In the last 4 quarters, TMDX has beaten the revenue estimates by 4.1% on average.
Related analysis
TRANSMEDICS GROUP INC / TMDX Earnings FAQ
Can you provide information on whether TRANSMEDICS GROUP INC beat earnings estimates in the last quarter?
TRANSMEDICS GROUP INC (TMDX) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does TRANSMEDICS GROUP INC (TMDX) beat earnings estimates?
In the last 4 quarters, TRANSMEDICS GROUP INC (TMDX) has beaten EPS estimates in 4 out of 4 releases.